Sign in

Dr. Ieva Saulite

Dermatologie | Venerologie | Allergologie · Dept. IV

Jan 18, 2022
A multicenter, prospective observational RWE study to assess Patient-reported wellbeing using tildrakizumab in a live setting – POSITIVE Study
Jan 18, 2022

Clinical Studies - Jan 18, 2022 - Dec 31, 2024

Ongoing

Project leader: Saulite Ieva

more

We use cookies and tracking technologies according to our privacy policy to provide you with the best possible web experience. To the privacy policy